mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.07 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.07 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.07 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.08 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.08 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |